Curaleaf Holdings, Inc.
TSXCURA enters September with an unusual combination: a stock that has gained 10% over the past month, short sellers quietly exiting, and a 90th-percentile earnings estimate momentum reading — yet its closest peers are mostly heading the other way this week. The clearest setup in the lending market is one of indifference rather than aggression. Short interest has drifted lower all…
Snapshot as of 20 Sept 2026
CURA enters September with an unusual combination: a stock that has gained 10% over the past month, short sellers quietly exiting, and a 90th-percentile earnings estimate momentum reading — yet its closest peers are…
CURA has lost 15% over the past month and nearly 10% in the past week alone, making it one of the sharper decliners in a cannabis peer group that is broadly under pressure — the question now is whether the stock is…
CURA headed into its Q1 2026 earnings with short sellers already retreating — and the results gave them little reason to return. The company posted Q1 EPS of $0.09, against a consensus estimate of $(0.06) — a $0.15…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CURA — free to start on ORTEX.
Sign up for free →Open CURA on ORTEX